ambroxol
UkraineDrugs containing this active substance
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired secretion and excretion of phlegm. This includes bronchitis, pneumonia, bronchial asthma, laryngitis, tracheitis, and other diseases.
Form: powder for oral suspension
Active substance Dosage acetylcysteine 200 mg ambroxol 30 mg ATC: R05CB10
Manufacturer: Sava HealthCare Ltd
-
The drug is used to treat acute and chronic respiratory diseases (e.g., bronchitis, pneumonia) accompanied by impaired mucus clearance. It also helps with rhinitis, sinusitis, and otitis by reducing swelling and thinning secretions.
Form: powder for oral suspension
Active substance Dosage ambroxol 30 mg/5 ml loratadine 5 mg/5 ml ATC: R05C
Manufacturer: Sava HealthCare Ltd
-
The drug is used to treat acute and chronic respiratory diseases (e.g., bronchitis, pneumonia) accompanied by impaired sputum clearance. It also helps with allergic rhinitis, sinusitis, and otitis to reduce swelling and thin the secretion.
Form: tablets
Active substance Dosage ambroxol 60 mg loratadine 5 mg ATC: R05C
Manufacturer: Sava HealthCare Ltd
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired secretion and excretion of phlegm (e.g., bronchitis, pneumonia, bronchial asthma, laryngitis, tracheitis, and others).
Form: tablets, film-coated
Active substance Dosage acetylcysteine 200 mg ambroxol 30 mg ATC: R05CB10
Manufacturer: Evertoxgen Life Sciences Limited
-
The drug is used for the symptomatic treatment of respiratory diseases that have an allergic component and are accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 60 mg loratadine 5 mg ATC: R05C
Manufacturer: Evertoxgen Life Sciences Limited
-
The drug is used for the treatment of acute and chronic bronchial diseases accompanied by difficulties in mucus excretion. It also helps relieve severe throat pain in uncomplicated respiratory diseases in adults.
Form: solution, oral
Active substance Dosage ambroxol 50 mg/ml ATC: R05CB06
Manufacturer: ITC Production S.R.L.
-
The drug is used for the treatment of bronchial asthma, chronic obstructive bronchitis, and pulmonary emphysema.
Form: tablets
Active substance Dosage ambroxol 15 mg salbutamol 4 mg ATC: R03AK04
Manufacturer: PJSC "Scientific and Production Center "Boryspilskyy Chemical-Pharmaceutical Plant" (full-cycle manufacturing)